NCT04651010Recruiting
Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)
Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months. We aim to find early radiologic predictive factors for favorable clinical outcome in this population of patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 25 Nov 2020
- Start date
- Nov 2021
- Primary completion date
- Aug 2028
- Lead sponsor
- Poitiers University Hospital
- Diseases
- Stroke
- NCT number
- NCT04651010
What you commit to
- Study type: Interventional
- Planned participants: 50
- From Nov 2021 to the primary completion date, Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients or relatives whom a loyal information about the study cannot be given
- Patient with cognitive impairments before MRI.
- Patients who cannot undergo MRI because of contraindications
- Patients too deteriorated to tolerate one hour long exam
Who the study is looking for
- Patients aged ≥ 18 years old
- Hospitalized at the Poitiers University Hospital
- Acute middle cerebral artery occlusion diagnosed by CT-scan or MRI
- NIHSS score ≥ 6 at admission
- To be treated by thrombectomy with or without fibrinolysis
- Written information delivered to the patient or his relatives concerning the study and its benefit and risk
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Poitiers Coordinator of this site? Confirm its status | Poitiers | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.